HS

Helen Schiltz

Chief Operating Officer

OncoC4, Inc.

Rockville, Maryland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
OncoC4, Inc.
Industry
pharmaceuticals
Employees
63.0
Seniority
C suite
Annual Revenue
2000000.0

Technologies

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting Mobile Friendly reCAPTCHA AddThis Google Font API WordPress.org Joomla Nginx Remote AI

Keywords

pharmaceutical manufacturing immunotherapy cancer treatment pd-1 vegf ctla-4 siglec cd24 bispecific antibodies monoclonal antibodies antibody-drug conjugates car t-cell therapies neurodegenerative diseases alzheimer's disease tumor microenvironment immune checkpoints immunotherapy resistance antibody therapies clinical pipeline cancer-specific antibodies solid tumors hematologic malignancies clinical trials targeted therapy immune response cell-cell interaction antitumor activity ph-sensitive antibodies immune-related adverse events oncology cancer research immune modulation phase 1 trial phase 2 trial phase 3 trial therapeutic strategies immune escape safety profile efficacy drug development novel targets clinical efficacy antibody design treatment modalities cellular signaling cancer cells therapeutic platform chronic diseases novel checkpoints pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans